About Us

Mission: To evenly scaffold all bifurcations regardless of angles, sizes or plaque location in a simple procedure.

Advanced Bifurcation Systems® has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology.

The ABS® platform is protected by more than 36 issued and 12 pending patents and will become the “standard of care” in the $2.5 billion global bifurcations market.

Every year millions of patients around the world with heart disease present to doctors who find they are faced with either a Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG). Advanced Bifurcation Systems ™ or ABS wants to transform the open heart surgery.

A quarter of those requiring stenting will have bifurcation lesions, meaning a build-up of plaque that is blocking or about to block blood flow to the heart at a place where the blood vessel divides in two. That condition, until now, has had no best practice solution. Interventional cardiologists have used a variety of procedures that are all, to put it kindly, “adapted” from the world of conventional straight vessel stenting using techniques that are risky, tedious, complicated and are likely to lead to poor clinical outcomes.

ABS™ has a system in development that has the potential to transform stenting practice for coronary bifurcation lesions and represents an opportunity to become the standard of best practice in PCI for these lesions in the years ahead. It even represents an opportunity to introduce PCI to many more left main artery procedures. Cardiologists will recognize the ABS system immediately as easy to use and will note how simple it is to avoid the positioning and mechanical problems they experience during the PCI procedures they use now. Our system will reduce risk, improve clinical outcomes, save procedure time, cut recovery time and reduce cost.

Download the ABS Company Fact Sheet and the Management Presentation

Standard PCI Catheter Delivery

Every year patients with heart disease, and there are more than 60 million people with coronary heart disease in the US alone, present to doctors around the world and find they are faced with a PCI or CABG procedure.

A quarter of those requiring stenting will have bifurcation lesions, meaning a build-up of plaque that is blocking or about to block blood flow to their heart at a place where the blood vessel divides in two, that condition, until now, has had no best practice solution. Interventional cardiologists have used a variety of procedures that are all, to put it kindly, “adapted” from the world of conventional straight vessel stenting using techniques that are risky, tedious, complicated and are likely to lead to poor clinical outcomes.

Over $2 billion is spent in this way annually on the stenting alone without counting the cost of additional time in recovery, additional post-op procedures or the patients who wind up with CABG because PCI is too risky or difficult to execute correctly.

Advanced Bifurcation Systems ™ has a system that transforms stenting practice for coronary bifurcation lesions and represents an opportunity to become the standard of best practice in PCI for these lesions in the years ahead. Our Platform will revolutionize medical practice. Cardiologists will recognize it immediately as easy to use and will note how simple it is to avoid the positioning and mechanical problems they have in the procedures they use.

Learn More

Proprietary ABS™ Stenting System

Advanced Bifurcation Systems ™ has a solution that will be familiar to cardiologists worldwide. By the nature of the built-in way the system is introduced into the main and branch vessels and the stents fed to precise points at precise moments, you have fail-safe alignment that at once conquers the problem that has defeated all the other dedicated systems and the adapted or improvised techniques used to date.

1. The system is mechanically fail-safe. The automatic main vessel aperture and side vessel alignment prevent the need for torquing or micro alignment that mitigates outcome risks and prolonged procedure time and cost

 

2. The installation leaves no gaps, no overlapping and therefore significantly reduces the risk of readmission for thrombosis or restenosis.

Advanced Bifurcation Systems ™ stenting platform is a major step forward for the practice of stenting in bifurcation lesions. Interventional cardiologists will recognize the procedure and will be confident of the introduction of this kind of device through the catheters they use every day.

The revolutionary nature of the system is: how easy it is to install and how well it works. The risk profile of the bifurcation stenting procedure is radically reduced.

The ABS™ platform makes a procedure that takes less than ten minutes possible in large numbers of the bifurcation cases a cardiologist faces. This represents a revolution for the most important people in the equation of the pathway of care – the physician and his patient. We expect others will be excited too – those who look after the patient post-op will see faster recovery times and those who pay for the procedure will be excited that the cost of managing heart disease has been lowered significantly.


2 Comments

Trudy Nichols

May 7, 2018 at 6:12 pm

Hello,
I have worked in both the neurovascular and cardiovascular sectors and saw your website. Your product innovation is very intriguing to me. I am currently looking for new opportunities and am interested in learning whether ABS has an opportunity for quality assurance leadership. I have worked in the medical device sector for over 20+ years, mostly start-up companies but some mid-size as well, successfully developing and implementing ISO and FDA compliant quality systems. I would be happy to explore how we may beneficially serve each other. I can be reached through my email below.

    admin

    May 10, 2018 at 5:23 pm

    we have forwarded this to our human resources dept. Thank you for inquiring.

Leave a Reply